Esophageal Squamous Cell Carcinoma Clinical Trials

There are 11 registered clinical trials for Esophageal Squamous Cell Carcinoma in the TrialLens index.

Trials (11)

• Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC Phase 2 · Tang-Du Hospital
• Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma Phase 2 · BeiGene
• Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma Phase 2 · Chinese Academy of Medical Sciences
• Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）. Phase 2 · Henan Cancer Hospital
• Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma Phase 2 · Second Affiliated Hospital, Zhejiang University, School of Medicine
• Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma N/A · The First Affiliated Hospital with Nanjing Medical University
• Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC Phase 1/2 · Jiangsu Cancer Institute & Hospital
• A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors Phase 1 · Seagen, a wholly owned subsidiary of Pfizer
• Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer. Phase 2 · Sun Yat-sen University
• Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903) Phase 3 · Henan Cancer Hospital
• A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States Phase 2 · BeOne Medicines

Related landscapes

• Phase 1/2 Esophageal Squamous Cell Carcinoma
• Phase 2 Esophageal Squamous Cell Carcinoma
• Phase 3 Esophageal Squamous Cell Carcinoma
• N/A Esophageal Squamous Cell Carcinoma
• Phase 1 Esophageal Squamous Cell Carcinoma

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.